|
1
|
Donohue JH, Stewart AK and Menck HR: The
National Cancer Data Base report on carcinoma of the gallbladder,
1989–1995. Cancer. 83:2618–2628. 1998.PubMed/NCBI
|
|
2
|
Cubertafond P, Gainant A and Cucchiaro G:
Surgical treatment of 724 carcinomas of the gallbladder. Results of
the French Surgical Association Survey. Ann Surg. 219:275–280.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartlett DL, Fong Y, Fortner JG, Brennan
MF and Blumgart LH: Long-term results after resection for
gallbladder cancer. Implications for staging and management. Ann
Surg. 224:639–646. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Egberts JH, Cloosters V, Noack A, et al:
Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth
and metastasis. Cancer Res. 68:1443–1450. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zins K, Abraham D, Sioud M and Aharinejad
S: Colon cancer cell-derived tumor necrosis factor-alpha mediates
the tumor growth-promoting response in macrophages by up-regulating
the colony-stimulating factor-1 pathway. Cancer Res. 67:1038–1045.
2007. View Article : Google Scholar
|
|
6
|
Stathopoulos GT, Kollintza A, Moschos C,
et al: Tumor necrosis factor-alpha promotes malignant pleural
effusion. Cancer Res. 67:9825–9834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scott KA, Moore RJ, Arnott CH, et al: An
anti-tumor necrosis factor-alpha antibody inhibits the development
of experimental skin tumors. Mol Cancer Ther. 2:445–451.
2003.PubMed/NCBI
|
|
8
|
Michalaki V, Syrigos K, Charles P and
Waxman J: Serum levels of IL-6 and TNF-alpha correlate with
clinicopathological features and patient survival in patients with
prostate cancer. Br J Cancer. 90:2312–2316. 2004.PubMed/NCBI
|
|
9
|
Soria G, Ofri-Shahak M, Haas I, et al:
Inflammatory mediators in breast cancer: coordinated expression of
TNFα and IL-1β with CCL2 & CCL5 and effects on
epithelial-to-mesenchymal transition. BMC Cancer.
11:1302011.PubMed/NCBI
|
|
10
|
Radhakrishnan P, Chachadi V, Lin MF, Singh
R, Kannagi R and Cheng PW: TNFα enhances the motility and
invasiveness of prostatic cancer cells by stimulating the
expression of selective glycosyl- and sulfotransferase genes
involved in the synthesis of selectin ligands. Biochem Biophys Res
Commun. 409:436–441. 2011.
|
|
11
|
Kulbe H, Thompson R, Wilson JL, et al: The
inflammatory cytokine tumor necrosis factor-alpha generates an
autocrine tumor-promoting network in epithelial ovarian cancer
cells. Cancer Res. 67:585–592. 2007. View Article : Google Scholar
|
|
12
|
Akiyama M, Hideshima T, Hayashi T, et al:
Nuclear factor-kappaB p65 mediates tumor necrosis factor
alpha-induced nuclear translocation of telomerase reverse
transcriptase protein. Cancer Res. 63:18–21. 2003.
|
|
13
|
Li J, Sejas DP, Zhang X, et al: TNF-alpha
induces leukemic clonal evolution ex vivo in Fanconi anemia group C
murine stem cells. J Clin Invest. 117:3283–3295. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan B, Wang H, Rabbani ZN, et al: Tumor
necrosis factor-alpha is a potent endogenous mutagen that promotes
cellular transformation. Cancer Res. 66:11565–11570. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komori J, Marusawa H, Machimoto T, et al:
Activation-induced cytidine deaminase links bile duct inflammation
to human cholangiocarcinoma. Hepatology. 47:888–896. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Vincent A, Cates J, Brantley-Sieders
DM, Polk DB and Young PP: Low levels of tumor necrosis factor alpha
increase tumor growth by inducing an endothelial phenotype of
monocytes recruited to the tumor site. Cancer Res. 69:338–348.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hagemann T, Wilson J, Kulbe H, et al:
Macrophages induce invasiveness of epithelial cancer cells via
NF-kappa B and JNK. J Immunol. 175:1197–1205. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kulbe H, Hagemann T, Szlosarek PW,
Balkwill FR and Wilson JL: The inflammatory cytokine tumor necrosis
factor-alpha regulates chemokine receptor expression on ovarian
cancer cells. Cancer Res. 65:10355–10362. 2005. View Article : Google Scholar
|
|
19
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johnston DA, Dong B and Hughes CC: TNF
induction of jagged-1 in endothelial cells is NFkappaB-dependent.
Gene. 435:36–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cox GW, Melillo G, Chattopadhyay U, Mullet
D, Fertel RH and Varesio L: Tumor necrosis factor-alpha-dependent
production of reactive nitrogen intermediates mediates IFN-gamma
plus IL-2-induced murine macrophage tumoricidal activity. J
Immunol. 149:3290–3296. 1992.
|
|
22
|
Balkwill F: Tumor necrosis factor or tumor
promoting factor? Cytokine Growth Factor Rev. 13:135–141. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Naylor MS, Stamp GW, Foulkes WD, Eccles D
and Balkwill FR: Tumor necrosis factor and its receptors in human
ovarian cancer. Potential role in disease progression. J Clin
Invest. 91:2194–2206. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szlosarek PW, Grimshaw MJ, Kulbe H, et al:
Expression and regulation of tumor necrosis factor alpha in normal
and malignant ovarian epithelium. Mol Cancer Ther. 5:382–390. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Homma S, Hasumura S, Nagamori S and Kameda
H: Establishment and characterization of a human gall bladder
carcinoma cell line NOZ. Hum Cell. 1:95–97. 1988.(In Japanese).
|
|
26
|
Carswell EA, Old LJ, Kassel RL, Green S,
Fiore N and Williamson B: An endotoxin-induced serum factor that
causes necrosis of tumors. Proc Natl Acad Sci USA. 72:3666–3670.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Waters JP, Pober JS and Bradley JR: Tumour
necrosis factor in infectious disease. J Pathol. 230:132–147. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blonska M, Shambharkar PB, Kobayashi M, et
al: TAK1 is recruited to the tumor necrosis factor-alpha
(TNF-alpha) receptor 1 complex in a receptor-interacting protein
(RIP)-dependent manner and cooperates with MEKK3 leading to
NF-kappaB activation. J Biol Chem. 280:43056–43063. 2005.
View Article : Google Scholar
|
|
29
|
Devin A, Lin Y, Yamaoka S, Li Z, Karin M
and Liu Z: The alpha and beta subunits of IkappaB kinase (IKK)
mediate TRAF2-dependent IKK recruitment to tumor necrosis factor
(TNF) receptor 1 in response to TNF. Mol Cell Biol. 21:3986–3994.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Jiang L, She F, et al: Vascular
endothelial growth factor-C promotes the growth and invasion of
gallbladder cancer via an autocrine mechanism. Mol Cell Biochem.
345:77–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin W, Jiang L, Chen Y, et al: Vascular
endothelial growth factor-D promotes growth, lymphangiogenesis and
lymphatic metastasis in gallbladder cancer. Cancer Lett.
314:127–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao X, Zhou L, Han S and Chen Y: High
expression of CXCR4 and CXCR7 predicts poor survival in gallbladder
cancer. J Int Med Res. 39:1253–1264. 2011. View Article : Google Scholar : PubMed/NCBI
|
